| lncRNA name in article | Virus & Strain Name | Dosage & Time point | Cell line | Experiment Type | Fold change | Expression | P-value | Differential expression quantification method | Statistical method | Year | PubMed ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SNHG1 | Enterovirus 71 (GDFS-3 strain of EV 71) | 10^2 TCID50/mL ;
24 hr |
RD Human embryonal rhabdomyosarcoma cells | RNA-Seq | 2.0873523 | Upregulation | p < 0.05 | GeneSpring GX v12.0 software package (Agilent Technologies) | Not provided | 2013 | 23220233 |
| SNHG1 | Coxsackie virus B3 (CG strain of CVB3) | MOI = 0.5 ;
23 hr |
HeLa Human papillomavirus-related endocervical adenocarcinoma cells | Microarray | 2.335978 | Upregulation | 0.00016 | GeneSpring GX v11.5.1 software package (Agilent Technologies) | student's t test | 2019 | 31388922 |
| SNHG1 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells | RNA-Seq | 3.097877293 | Upregulation | 4.91E-50 | student's t test | 2020 | 32416070 | |
| SNHG1 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 0.2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells (ACE2+) | RNA-Seq | 2.232159315 | Upregulation | 0 | student's t test | 2020 | 32416070 | |
| SNHG1 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells (ACE2+) | RNA-Seq | 4.232883701 | Upregulation | 3.66E-147 | student's t test | 2020 | 32416070 |
* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose